View Related Items
Category 6 - PATHOLOGY SERVICES
PN.7.10
Somatic gene testing for the diagnosis and characterisation of gliomas - Item 73429
Testing should include, but not be restricted to, genes described in the current World Health Organization Classification of Tumours.
Related Items: 73429
Related Items
Category 6 - PATHOLOGY SERVICES
73429 - Additional Information
Genetic testing (including characterisation of single nucleotide variants, structural variants, fusions and copy number alterations) in a single gene panel, requested by a specialist or consultant physician, for a patient with clinical or laboratory evidence of a glioma, glioneuronal tumour or glioblastoma, to aid diagnosis and classification of the relevant tumour, including assessments of at least the following kinds:
(a) IDH1, IDH2—variant testing;
(b) 1p/19q—co‑deletion assessment;
(c) H3F3A—variant status;
(d) TERT—promoter variant status;
(e) EGFR—amplification;
(f) CDKN2A/B—deletion;
(g) BRAF—variants
Applicable to one test per diagnostic episode
Fee: $887.90 Benefit: 75% = $665.95 85% = $789.20
(See para PN.7.10 of explanatory notes to this Category)
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change